Oncocytic papillary renal cell carcinoma with inverted nuclear pattern: Distinct subtype with an indolent clinical course

Pathology International

Volumn 59, Issue 3, 2009, Pages 137-146

  Park, Bong Hee ^a   Ro, Jae Y ^a   Park, Won Seo ^b   Jee, Kowan J ^c   Kim, Kyungeun ^a   Gong, Gyungyub ^a   Cho, Yong Mee ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b National Cancer Center   (South Korea)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Kidney; Oncocytic tumors; Papillary renal cell carcinoma; Prognosis

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; CD15 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN 20; CYTOKERATIN 7; EPITHELIAL MEMBRANE ANTIGEN; MUCIN 1; ONCOPROTEIN; PROTEIN MOC 31; STEM CELL FACTOR RECEPTOR; TUMOR MARKER; UNCLASSIFIED DRUG; UVOMORULIN; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CHROMOSOME 11Q; CHROMOSOME 17Q; CHROMOSOME 3P; CHROMOSOME 4Q; CHROMOSOME LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MALE; ONCOCYTIC PAPILLARY RENAL CELL CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECURRENT DISEASE;

AGED; CARCINOMA, RENAL CELL; CELL NUCLEUS; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; TISSUE ARRAY ANALYSIS;

EID: 60649108664     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2009.02341.x     Document Type: Article

References (31)

1. Gudbjartsson T, Hardarson S, Petursdottir V et al. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: A retrospective nation-wide study of 629 patients. Eur Urol 2005 48 : 593 600.
2. Lohse CM, Cheville JC. A review of prognostic pathologic features and algorithms for patients treated surgically for renal cell carcinoma. Clin Lab Med 2005 25 : 433 64.
3. Delahunt B, Eble JN. Papillary renal cell carcinoma: A clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol 1997 10 : 537 44.
4. Pignot G, Elie C, Conquy S et al. Survival analysis of 130 patients with papillary renal cell carcinoma: Prognostic utility of type 1 and type 2 subclassification. Urology 2007 69 : 230 35.
5. Kosaka T, Mikami S, Miyajima A et al. Papillary renal cell carcinoma: Clinicopathological characteristics in 40 patients. Clin Exp Nephrol 2008 12 : 195 9.
6. Argani P, Epstein JI. Inverted (hobnail) high-grade prostatic intraepithelial neoplasia (PIN): Report of 15 cases of a previously undescribed pattern of high-grade PIN. Am J Surg Pathol 2001 25 : 1534 9.
7. Allory Y, Ouazana D, Boucher E, Thiounn N, Vieillefond A. Papillary renal cell carcinoma. Prognostic value of morphological subtypes in a clinicopathologic study of 43 cases. Virchows Arch 2003 442 : 336 42.
8. Lefevre M, Couturier J, Sibony M et al. Adult papillary renal tumor with oncocytic cells: Clinicopathologic, immunohistochemical, and cytogenetic features of 10 cases. Am J Surg Pathol 2005 29 : 1576 81.
9. Hes O, Brunelli M, Michal M et al. Oncocytic papillary renal cell carcinoma: A clinicopathologic, immunohistochemical, ultrastructural, and interphase cytogenetic study of 12 cases. Ann Diagn Pathol 2006 10 : 133 9.
10. Kunju LP, Wojno K, Wolf JS Jr., Cheng L, Shah RB. Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: Expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical and molecular features. Hum Pathol 2008 39 : 96 101.
11. Eble JN, Sauter G, Epstein JI, Sesterhenn IA, eds. World Health Organization Classification of Tumors. Lyon : IARC Press, 2004.
12. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982 6 : 655 63.
13. Sika-Paotonu D, Bethwaite PB, McCredie MR, William Jordan T, Delahunt B. Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma. Am J Surg Pathol 2006 30 : 1091 6.
14. Greene FL, Page DL, Fleming ID et al. AJCC Cancer Staging Manual, 6th edn. Chicago : Springer-Verlag, 2002.
15. Amin MB, Amin MB, Tamboli P et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: An experience of 405 cases. Am J Surg Pathol 2002 26 : 281 91.
16. Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 2003 27 : 612 24.
17. Delahunt B, Eble JN, McCredie MR et al. Morphologic typing of papillary renal cell carcinoma: Comparison of growth kinetics and patient survival in 66 cases. Hum Pathol 2001 32 : 590 95.
18. Gunawan B, von Heydebreck A, Fritsch T et al. Cytogenetic and morphologic typing of 58 papillary renal cell carcinomas: Evidence for a cytogenetic evolution of type 2 from type 1 tumors. Cancer Res 2003 63 : 6200 205.
19. Leroy X, Zini L, Leteurtre E et al. Morphologic subtyping of papillary renal cell carcinoma: Correlation with prognosis and differential expression of MUC1 between the two subtypes. Mod Pathol 2002 15 : 1126 30.
20. Delahunt B, Bethwaite PB, Nacey JN. Outcome prediction for renal cell carcinoma: Evaluation of prognostic factors for tumours divided according to histological subtype. Pathology 2007 39 : 459 65.
21. Kovacs G, Fuzesi L, Emanual A, Kung HF. Cytogenetics of papillary renal cell tumors. Genes Chromosomes Cancer 1991 3 : 249 55.
22. Corless CL, Aburatani H, Fletcher JA et al. Papillary renal cell carcinoma: Quantitation of chromosomes 7 and 17 by FISH, analysis of chromosome 3p for LOH, and DNA ploidy. Diagn Mol Pathol 1996 5 : 53 64.
23. Jiang F, Richter J, Schraml P et al. Chromosomal imbalances in papillary renal cell carcinoma: Genetic differences between histological subtypes. Am J Pathol 1998 153 : 1467 73.
24. Sanders ME, Mick R, Tomaszewski JE, Barr FG. Unique patterns of allelic imbalance distinguish type 1 from type 2 sporadic papillary renal cell carcinoma. Am J Pathol 2002 161 : 997 1005.
25. Yang XJ, Tan MH, Kim HL et al. A molecular classification of papillary renal cell carcinoma. Cancer Res 2005 65 : 5628 37.
26. Tretiakova MS, Sahoo S, Takahashi M et al. Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma. Am J Surg Pathol 2004 28 : 69 76.
27. Zhou M, Roma A, Magi-Galluzzi C. The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms. Clin Lab Med 2005 25 : 247 57.
28. Pan CC, Chen PC, Ho DM. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: An immunohistochemical analysis of 328 cases. Histopathology 2004 45 : 452 9.
29. Schrader AJ, Olbert PJ, Hegele A, Varga Z, Hofmann R. Metastatic non-clear cell renal cell carcinoma: Current therapeutic options. BJU Int 2008 101 : 1343 5.
30. Yamazaki K, Sakamoto M, Ohta T et al. Overexpression of KIT in chromophobe renal cell carcinoma. Oncogene 2003 22 : 847 52.
31. Pan CC, Chen PC, Chiang H. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma. Am J Clin Pathol 2004 121 : 878 83.